CytoDyn Inc.

CYDY - Therapeutics For Jun 2020

Among Covid-19 therapeutic drugs (not vaccines) with the most advanced trials that would make news within the next weeks appears to be Cytodyn-CYDY (leading the list) MESO, ATHX, HGEN. Cytodyn has made an statement anouncing the unblinding on June 15th, 2020 of Leronlimab results on fase 2b/3 trial for Covid-19. The key point seems to be that those trials are also running for brand positioning of CYDY`s drug Leronlimab that has an impresive track record as a therapeutic that is extensive for the treatment of other different diseases that make it unique.

면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.